ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,173,000 | -70.0% | 7,964 | -74.3% | 0.00% | -75.0% |
| Q3 2016 | $3,914,000 | -55.5% | 30,967 | -60.3% | 0.00% | -55.6% |
| Q2 2016 | $8,802,000 | -15.3% | 78,067 | -21.8% | 0.01% | -18.2% |
| Q1 2016 | $10,394,000 | -16.4% | 99,848 | -9.4% | 0.01% | -15.4% |
| Q4 2015 | $12,433,000 | -2.3% | 110,238 | -5.1% | 0.01% | -7.1% |
| Q3 2015 | $12,725,000 | +65.4% | 116,207 | +44.5% | 0.01% | +75.0% |
| Q2 2015 | $7,694,000 | +21.0% | 80,434 | +17.8% | 0.01% | +14.3% |
| Q1 2015 | $6,359,000 | +51.1% | 68,275 | +32.9% | 0.01% | +75.0% |
| Q4 2014 | $4,209,000 | +0.8% | 51,388 | -21.0% | 0.00% | 0.0% |
| Q3 2014 | $4,175,000 | -13.3% | 65,050 | -17.9% | 0.00% | -20.0% |
| Q2 2014 | $4,817,000 | +19.8% | 79,210 | +17.9% | 0.01% | +25.0% |
| Q1 2014 | $4,022,000 | -38.2% | 67,161 | -34.3% | 0.00% | -33.3% |
| Q4 2013 | $6,513,000 | -53.8% | 102,228 | -50.8% | 0.01% | -57.1% |
| Q3 2013 | $14,112,000 | +457.8% | 207,750 | +491.8% | 0.01% | +366.7% |
| Q2 2013 | $2,530,000 | – | 35,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |